Fig. 2

The 6-year cumulative incidence of MACE. The 6-year MACE rate was significantly higher in the ST-ACS with HD group, followed by the de novo-ACS with HD, ST-ACS without HD, and de novo-ACS without HD groups, indicating worse outcomes in patients on HD with ACS due to ST. *Statistically significant at p = 0.05 after Holm’s correction for multiple comparisons. ACS, acute coronary syndrome; CI, confidence interval; HD, hemodialysis; HR, hazard ratio; MACE, major adverse cardiac events; ST, stent thrombosis.